|
76
|
|
18
|
+9
|
+100%
|
US$100만
|
|
|
77
|
|
17
|
-1
|
-6%
|
US$27만
|
|
|
78
|
|
17
|
+2
|
+13%
|
US$15.5만
|
|
|
79
|
|
16
|
-11
|
-41%
|
US$64.1만
|
|
|
80
|
|
16
|
+2
|
+14%
|
US$5.53만
|
|
|
81
|
Creative Medical Technology
|
15
|
+4
|
+36%
|
US$54.1만
|
|
|
82
|
|
15
|
-1
|
-6%
|
US$499만
|
|
|
83
|
|
9
|
-6
|
-40%
|
US$23.6만
|
|
|
84
|
|
9
|
-2
|
-18%
|
US$133만
|
|
|
85
|
|
9
|
+9
|
–
|
US$278만
|
|
|
86
|
상장폐지됨
SANGAMO THERAPEUTICS INC
|
6
|
-107
|
-95%
|
US$2.9만
|
|
|
87
|
|
4
|
0
|
0%
|
US$4.26만
|
|
|
88
|
상장폐지됨
Achilles Therapeutics
|
3
|
0
|
0%
|
US$9.9만
|
|
|
89
|
|
3
|
0
|
0%
|
US$1.22만
|
|
|
90
|
|
2
|
-238
|
-99%
|
US$343만
|
|
|
91
|
상장폐지됨
Athersys, Inc. Common Stock
|
1
|
0
|
0%
|
–
|
|
|
92
|
상장폐지됨
Carisma Therapeutics
|
1
|
-2
|
-67%
|
US$4
|
|
|
93
|
|
1
|
0
|
0%
|
US$63
|
|
|
94
|
|
1
|
-1
|
-50%
|
US$0
|
|
|
95
|
상장폐지됨
NKGen Biotech, Inc. Common Stock
|
1
|
0
|
0%
|
US$16.5만
|
|
|
96
|
상장폐지됨
Scorpius Holdings, Inc.
|
1
|
0
|
0%
|
US$1
|
|
|
97
|
상장폐지됨
Sio Gene Therapies Inc. Common Stock
|
1
|
+1
|
–
|
US$23.5만
|
|
|
98
|
상장폐지됨
Adaptimmune Therapeutics
|
0
|
-1
|
-100%
|
US$0
|
|
|
99
|
상장폐지됨
Adverum Biotechnologies
|
–
|
–
|
–
|
–
|
|
|
100
|
상장폐지됨
Applied Genetic Technologies Corporation
|
–
|
–
|
–
|
–
|
|
